← Back to Clinical Trials
Recruiting NCT06320106

NCT06320106 Assessment of Navigation Abilities in Children With Cerebral Palsy and Their Peers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06320106
Status Recruiting
Phase
Sponsor IRCCS Eugenio Medea
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2023-02-07
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Virtual Reality baseline assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2023-02-07 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Spatial navigation skills are very important in everyday activities and quality of life but spatial navigation abilities are not part of the standard process of assessment and rehabilitation of patients. Furthermore, it is known that children with cerebral palsy have impaired visuo-spatial competences. The main objective of this study is to evaluate and compare the spatial navigation abilities of typically developing children and of children with cerebral palsy using the "StarMaze" application delivered by means of a Head Mounted Display (HMD). The second aim is to investigate the user experience during the session. A similar application was already developed and tested in a virtual reality large scale platform whose size and cost limit the accessibility. Therefore, the assessment (and future training) of navigation abilities with affordable and easy-to-use technology such as HMD open new perspectives.

Eligibility Criteria

Inclusion Criteria: * IQ higher than 70 Exclusion Criteria: * Subjects with epileptic issues * Subjects with poor head control * Visual acuity not correctable with eyeglasses

Contact & Investigator

Central Contact

Emilia Biffi, PhD

✉ emilia.biffi@lanostrafamiglia.it

📞 0039 031877862

Frequently Asked Questions

Who can join the NCT06320106 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06320106 currently recruiting?

Yes, NCT06320106 is actively recruiting participants. Contact the research team at emilia.biffi@lanostrafamiglia.it for enrollment information.

Where is the NCT06320106 trial being conducted?

This trial is being conducted at Bosisio Parini, Italy.

Who is sponsoring the NCT06320106 clinical trial?

NCT06320106 is sponsored by IRCCS Eugenio Medea. The trial plans to enroll 26 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology